OVARIAN EPITHELIAL CANCER RECURRENT

OVARIAN EPITHELIAL CANCER RECURRENT was reported 54 times

OVARIAN EPITHELIAL CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 4 0.0002
1 Microtubule Inhibitor [EPC] 23 0.0001
2 Platinum-based Drug [EPC] 27 0.0001
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 9 0.0000
4 BCL-2 Inhibitor [EPC] 2 0.0000
5 Topoisomerase Inhibitor [EPC] 2 0.0000
6 Leukocyte Growth Factor [EPC] 2 0.0000
7 HER2/neu Receptor Antagonist [EPC] 1 0.0000
8 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
9 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
10 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
11 Opioid Agonist [EPC] 1 0.0000